Ke Wu

1.4k total citations
72 papers, 1.0k citations indexed

About

Ke Wu is a scholar working on Finance, Molecular Biology and Epidemiology. According to data from OpenAlex, Ke Wu has authored 72 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Finance, 17 papers in Molecular Biology and 13 papers in Epidemiology. Recurrent topics in Ke Wu's work include Financial Markets and Investment Strategies (18 papers), Complex Systems and Time Series Analysis (10 papers) and Market Dynamics and Volatility (9 papers). Ke Wu is often cited by papers focused on Financial Markets and Investment Strategies (18 papers), Complex Systems and Time Series Analysis (10 papers) and Market Dynamics and Volatility (9 papers). Ke Wu collaborates with scholars based in China, United States and Canada. Ke Wu's co-authors include Lei Jiang, Jianjing Yang, Guofu Zhou, Qichuan Zhuge, Jiangnan Hu, Haoqi Ni, Wen‐Jie Zhou, Hui‐Li Yang, Ming‐Qing Li and Lijie Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Ke Wu

61 papers receiving 990 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ke Wu China 19 395 212 172 145 113 72 1.0k
Yubo Wang China 14 350 0.9× 105 0.5× 75 0.4× 135 0.9× 69 0.6× 70 965
Yanhong Yang China 19 316 0.8× 71 0.3× 87 0.5× 122 0.8× 8 0.1× 54 769
Jiaojiao Guo China 20 1.0k 2.6× 222 1.0× 200 1.2× 224 1.5× 44 0.4× 60 1.8k
Chunlian Zhang United States 18 973 2.5× 50 0.2× 98 0.6× 195 1.3× 19 0.2× 35 1.5k
Yating Wang China 14 192 0.5× 62 0.3× 107 0.6× 162 1.1× 21 0.2× 70 842
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani Netherlands 15 1.2k 3.1× 126 0.6× 244 1.4× 50 0.3× 19 0.2× 33 2.1k
Edward Li United States 13 291 0.7× 108 0.5× 58 0.3× 38 0.3× 26 0.2× 41 672
Ningyu Chen China 16 1.4k 3.5× 250 1.2× 83 0.5× 139 1.0× 17 0.2× 28 2.2k
Tao Dai China 15 408 1.0× 93 0.4× 135 0.8× 70 0.5× 17 0.2× 48 861
Zhongmin Zhou United States 22 487 1.2× 193 0.9× 94 0.5× 190 1.3× 25 0.2× 46 1.4k

Countries citing papers authored by Ke Wu

Since Specialization
Citations

This map shows the geographic impact of Ke Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Wu more than expected).

Fields of papers citing papers by Ke Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Wu. The network helps show where Ke Wu may publish in the future.

Co-authorship network of co-authors of Ke Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Ke Wu. A scholar is included among the top collaborators of Ke Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Wu. Ke Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shan, Changjuan, Jiaojiao Zhu, Jianhua Wang, et al.. (2025). Gene duplication and clustering underlie the conservation and diversification of benzylisoquinoline alkaloid biosynthesis in plants. Nature Communications. 16(1). 7669–7669. 1 indexed citations
2.
Wang, Jianqiu, et al.. (2024). Asymmetry and the cross-section of option returns. Journal of Financial Markets. 71. 100932–100932.
3.
Wu, Ke, Yuanyuan Zhang, Wei Xu, et al.. (2024). Transmission of carbapenem-resistant enterobacterales producing NDM-5 during the broiler breeding process in China. Veterinary Microbiology. 298. 110282–110282. 4 indexed citations
4.
Zhou, Fangyue, Xiaoling Yang, Ruru Liu, et al.. (2024). Reduced contrast sensitivity function and outer retina thickness in convalescent Vogt-Koyanagi-Harada disease. Eye. 39(2). 366–372.
5.
Wang, Jiaqi, Leiwen Fu, Meng Han, et al.. (2024). Knowledge, concerns, and vaccine acceptance related to Mpox (Monkeypox) among university students in North and Northeast China: An online cross-sectional study. Human Vaccines & Immunotherapeutics. 20(1). 2339922–2339922. 6 indexed citations
6.
Wang, Xianmin, Huijuan Li, Zhengxing Wu, et al.. (2024). Epidemiological trends and clinical characteristics of human leptospirosis in Wenzhou, Zhejiang Province, China, 2020–2022. The Journal of Infection in Developing Countries. 18(11). 1709–1714. 1 indexed citations
7.
Fu, Leiwen, Bingyi Wang, Ke Wu, et al.. (2024). Efforts made, challenges faced, and recommendations provided by stakeholders involved in mpox prevention and control in China: a qualitative study. Public Health. 236. 115–124. 3 indexed citations
8.
Yang, Yuan, Weijie Zhang, Meng Han, et al.. (2024). Mpox knowledge and vaccination hesitancy among healthcare workers in Beijing, China: A cross-sectional survey. Vaccine X. 16. 100434–100434. 5 indexed citations
9.
Wang, Jianqiu, et al.. (2023). Disagreement, speculation, and the idiosyncratic volatility. Journal of Empirical Finance. 72. 232–250. 3 indexed citations
10.
Lin, Dan, Ke Wu, Xia Zhao, et al.. (2022). Synergistic Effect of Combined Sub-Tenon Triamcinolone and Intravitreal Anti-VEGF Therapy for Uveitic Macular Edema. Drug Design Development and Therapy. Volume 16. 1055–1066. 1 indexed citations
11.
Li, Huanzheng, et al.. (2021). Mutation analysis and prenatal diagnosis of a family with congenital contractural arachnodactyly. Molecular Genetics & Genomic Medicine. 9(4). e1638–e1638. 1 indexed citations
12.
Zhang, Xingru, Zhiyu Jiang, Zengrui Zhang, et al.. (2020). <p>The Advantages of Levodopa-Carbidopa Intestinal Gel for Patients with Advanced Parkinson’s Disease: A Systematic Review</p>. Drug Design Development and Therapy. Volume 14. 845–854. 4 indexed citations
13.
Lin, Dan, Ke Wu, Ruru Liu, et al.. (2020). Evaluation of microvasculature alterations in convalescent Vogt-Koyanagi-Harada disease using optical coherence tomography angiography. Eye. 35(7). 1993–1998. 14 indexed citations
14.
Jiang, Lei, et al.. (2019). Stock Return Asymmetry: Beyond Skewness. Journal of Financial and Quantitative Analysis. 55(2). 357–386. 33 indexed citations
15.
Zhou, Wen‐Jie, Jie Zhang, Hui‐Li Yang, et al.. (2019). Estrogen inhibits autophagy and promotes growth of endometrial cancer by promoting glutamine metabolism. Cell Communication and Signaling. 17(1). 99–99. 65 indexed citations
16.
Wu, Ke, Dongdong Huang, Ying Zhang, et al.. (2019). NT3P75-2 gene-modified bone mesenchymal stem cells improve neurological function recovery in mouse TBI model. Stem Cell Research & Therapy. 10(1). 311–311. 27 indexed citations
17.
Zhang, Bing, Wen‐Jie Zhou, Chunjie Gu, et al.. (2018). The ginsenoside PPD exerts anti-endometriosis effects by suppressing estrogen receptor-mediated inhibition of endometrial stromal cell autophagy and NK cell cytotoxicity. Cell Death and Disease. 9(5). 574–574. 54 indexed citations
18.
Zhou, Wen‐Jie, Kai‐Kai Chang, Ke Wu, et al.. (2017). Rapamycin Synergizes with Cisplatin in Antiendometrial Cancer Activation by Improving IL-27–Stimulated Cytotoxicity of NK Cells. Neoplasia. 20(1). 69–79. 27 indexed citations
19.
Rong, Yuan, Chunhui Yuan, Zhen Qu, et al.. (2016). Doxorubicin resistant cancer cells activate myeloid-derived suppressor cells by releasing PGE2. Scientific Reports. 6(1). 23824–23824. 64 indexed citations
20.
Cao, Weijie, Ke Wu, Chong Wang, & Dingming Wan. (2016). Polydatin-induced cell apoptosis and cell cycle arrest are potentiated by Janus kinase 2 inhibition in leukemia cells. Molecular Medicine Reports. 13(4). 3297–3302. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026